{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:49:09Z","timestamp":1790844549915,"version":"4.1.0"},"reference-count":241,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001061","name":"Rebecca L. Cooper Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2018.01167","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:50:27Z","timestamp":1535025027000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension"],"prefix":"10.3389","volume":"9","author":[{"given":"Charmaine C. W.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed M.","family":"Moosavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Bubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/0026-0495(92)90303-R","article-title":"Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin.","volume":"41","author":"Abassi","year":"1992","journal-title":"Metabolism"},{"key":"B2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0143-4179(97)90028-7","article-title":"Differential effects of guanine nucleotides on [125I]-hCGRP(8-37) binding to porcine lung and human neuroblastoma cell membranes.","volume":"31","author":"Aiyar","year":"1997","journal-title":"Neuropeptides"},{"key":"B4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/01.sla.0000255577.80800.e1","article-title":"Transient receptor potential vanilloid 1 antagonist, capsazepine, improves survival in a rat hemorrhagic shock model.","volume":"245","author":"Akabori","year":"2007","journal-title":"Ann. Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"H1525","DOI":"10.1152\/ajpheart.00874.2012","article-title":"Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart.","volume":"304","author":"Al-Rubaiee","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.2994212","article-title":"Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide.","volume":"229","author":"Amara","year":"1985","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products.","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0008-6363(99)00115-7","article-title":"Enzymatic function of nitric oxide synthases.","volume":"43","author":"Andrew","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.117.028388","article-title":"A novel alpha-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure.","volume":"136","author":"Aubdool","year":"2017","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1164\/rccm.201508-1607ED","article-title":"Toward precision medicine in pulmonary arterial hypertension.","volume":"192","author":"Austin","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1476-5381.2010.01164.x","article-title":"New perspectives for the treatment of pulmonary hypertension.","volume":"163","author":"Baliga","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1164\/rccm.200801-121OC","article-title":"Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.","volume":"178","author":"Baliga","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension.","author":"Barst","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/nejm199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.","volume":"334","author":"Barst","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/ard.61.3.261","article-title":"Correlation between plasma concentrations of calcitonin gene related peptide and pulmonary pressure in patients with systemic sclerosis.","volume":"61","author":"Bartosik","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1476-5381.1993.tb13454.x","article-title":"Neurokinin-induced changes in pial artery diameter in the anaesthetized guinea-pig.","volume":"108","author":"Beattie","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1476-5381.1995.tb15043.x","article-title":"Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea-pig.","volume":"115","author":"Berthiaume","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0167-0115(02)00100-3","article-title":"Role of calcitonin gene-related peptide (CGRP) in chronic hypoxia-induced pulmonary hypertension in the mouse. Influence of gene transfer in vivo.","volume":"108","author":"Bivalacqua","year":"2002","journal-title":"Regul. Pept."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/oxfordjournals.humrep.a137823","article-title":"Smooth muscle dilatation in the human uterine artery induced by substance P, vasoactive intestinal polypeptide, calcitonin gene-related peptide and atrial natriuretic peptide: relation to endothelium-derived relaxing substances.","volume":"7","author":"Bodelsson","year":"1992","journal-title":"Hum. Reprod."},{"key":"B20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/oxfordjournals.humrep.a138580","article-title":"Endothelium-dependent relaxation to substance P in human umbilical artery is mediated via prostanoid synthesis.","volume":"9","author":"Bodelsson","year":"1994","journal-title":"Hum. Reprod."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.1021\/jm3009103","article-title":"The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N\u2019-p ropylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist.","volume":"55","author":"Bolli","year":"2012","journal-title":"J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1476-5381.1986.tb14589.x","article-title":"Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle.","volume":"87","author":"Bolton","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator.","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0366-0869(57)80076-8","article-title":"The lungs in heart disease.","volume":"51","author":"Brenner","year":"1957","journal-title":"Br. J. Tuberc. Dis. Chest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1378\/chest.120.3.809","article-title":"Intravascular ultrasound assessment of pulmonary vascular disease in patients with pulmonary hypertension.","volume":"120","author":"Bressollette","year":"2001","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/thx.51.1.89","article-title":"Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension.","volume":"51","author":"Brett","year":"1996","journal-title":"Thorax"},{"key":"B27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-1-4939-2636-7_15","author":"Bubb","year":"2015","journal-title":"\u201cModulation of cGMP Synthesis and Metabolism,\u201d in Diagnosis and Management of Pulmonary Hypertension"},{"key":"B28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.111.00942","article-title":"Activation of neuronal transient receptor potential vanilloid 1 channel underlies 20-hydroxyeicosatetraenoic acid-induced vasoactivity: role for protein kinase A.","volume":"62","author":"Bubb","year":"2013","journal-title":"Hypertension"},{"key":"B29","first-page":"2531","article-title":"Mechanisms of depletion of substance P by capsaicin.","volume":"44","author":"Burks","year":"1985","journal-title":"Fed. Proc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1378\/chest.114.1.178","article-title":"Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.","volume":"114","author":"Cailes","year":"1998","journal-title":"Chest"},{"key":"B31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway.","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/01.CIR.101.8.923","article-title":"In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse.","volume":"101","author":"Champion","year":"2000","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/newbio232086a0","article-title":"Amino-acid sequence of substance P.","volume":"232","author":"Chang","year":"1971","journal-title":"Nat. New Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jacc.2004.02.042","article-title":"Endothelin receptor antagonists in pulmonary arterial hypertension.","author":"Channick","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"L202","DOI":"10.1152\/ajplung.00064.2004","article-title":"Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells.","volume":"288","author":"Chattergoon","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.CIR.99.1.168","article-title":"Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and practice executive committee.","volume":"99","author":"Cheitlin","year":"1999","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1096\/fj.201701303R","article-title":"Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis.","volume":"32","author":"Chen","year":"2018","journal-title":"FASEB J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4077\/cjp.2012.amm103","article-title":"Oxygen radicals and substance P in perinatal hypoxia-exaggerated, monocrotaline-induced pulmonary hypertension.","volume":"55","author":"Chen","year":"2012","journal-title":"Chin. J. Physiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"H1543","DOI":"10.1152\/ajpheart.1999.276.5.H1543","article-title":"Chronic activation of neurokinin-1 receptor induces pulmonary hypertension in rats.","author":"Chen","year":"1999","journal-title":"Am. J. Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"G791","DOI":"10.1152\/ajpgi.1995.268.5.G791","article-title":"Interaction of endogenous nitric oxide and CGRP in sensory neuron-induced gastric vasodilation.","author":"Chen","year":"1995","journal-title":"Am. J. Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jvs.2010.05.095","article-title":"Mechanosensitive transient receptor potential vanilloid type 1 channels contribute to vascular remodeling of rat fistula veins.","volume":"52","author":"Chen","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"H935","DOI":"10.1152\/ajpheart.1996.270.3.H935","article-title":"Stimulation of atrial natriuretic peptide release by neurokinins in neonatal rat ventricular cardiomyocytes.","author":"Church","year":"1996","journal-title":"Am. J. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1164\/rccm.200602-165OC","article-title":"High frequency of BMPR2 exonic deletions\/duplications in familial pulmonary arterial hypertension.","volume":"174","author":"Cogan","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF00172588","article-title":"Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors.","volume":"344","author":"Constantine","year":"1991","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(98)00310-0","article-title":"Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary arteries.","volume":"350","author":"Corboz","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/13543784.2011.556617","article-title":"Combined neutral endopeptidase inhibitors.","volume":"20","author":"Cuculi","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jicd.12087","article-title":"Relationship between levels of neuropeptide Substance P in periodontal disease and chronic pain: a literature review.","volume":"5","author":"de Avila","year":"2014","journal-title":"J. Investig. Clin. Dent."},{"key":"B49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lfs.2014.04.012","article-title":"End O\u2019 The Line Revisited: moving on from nitric oxide to CGRP.","volume":"118","author":"De Mey","year":"2014","journal-title":"Life Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"11086","DOI":"10.1073\/pnas.190276697","article-title":"The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.","volume":"97","author":"DeFea","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijcard.2013.11.010","article-title":"Substance P in heart failure: the good and the bad.","volume":"170","author":"Dehlin","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1016\/j.ijcard.2013.07.190","article-title":"Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension.","volume":"168","author":"Dehlin","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2353\/ajpath.2009.080345","article-title":"Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.","volume":"174","author":"Dempsey","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/jir.s12978","article-title":"Role of the transient receptor potential vanilloid 1 in inflammation and sepsis.","volume":"4","author":"Devesa","year":"2011","journal-title":"J. Inflamm. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1749-6632.1992.tb22814.x","article-title":"Evidence for an increase in the release of CGRP from sensory nerves during inflammation.","volume":"657","author":"Donnerer","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-2999(85)90515-1","article-title":"Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium.","volume":"114","author":"D\u2019Orleans-Juste","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1645\/GE-596R1.1","article-title":"Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection.","volume":"93","author":"D\u2019Souza","year":"2007","journal-title":"J. Parasitol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/0002-9149(92)90736-I","article-title":"Effects of calcitonin gene-related peptide on cardiac contractility, coronary hemodynamics and myocardial energetics in idiopathic dilated cardiomyopathy.","volume":"70","author":"Dubois-Rande","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.105.581405","article-title":"Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling.","volume":"113","author":"Dumitrascu","year":"2006","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/08037059209077667","article-title":"Sensory nerve terminal activity in severe hypertension as reflected by circulating Calcitonin Gene-Related Peptide (CGRP) and substance P.","volume":"1","author":"Edvinsson","year":"1992","journal-title":"Blood Press."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1017\/s1462399411001979","article-title":"Diabetic neuropathy and heart failure: role of neuropeptides.","volume":"13","author":"Ejaz","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2147\/PPA.S30949","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes.","volume":"7","author":"Elshaboury","year":"2013","journal-title":"Patient Prefer. Adherence"},{"key":"B63","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1476-5381.1994.tb14026.x","article-title":"Mechanism underlying substance P-induced relaxation in dog isolated superficial temporal arteries.","volume":"111","author":"Enokibori","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"B64","first-page":"S172","article-title":"Substance P in human essential hypertension.","author":"Faulhaber","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/305534a0","article-title":"Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide.","volume":"305","author":"Fisher","year":"1983","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00424-010-0808-2","article-title":"Nitric oxide and oxidative stress in vascular disease.","volume":"459","author":"Forstermann","year":"2010","journal-title":"Pflugers Arch."},{"key":"B67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1378\/chest.10-0075","article-title":"The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.","volume":"139","author":"Frost","year":"2011","journal-title":"Chest"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1006\/bbrc.1994.1395","article-title":"Clearance of circulating endothelin-1 by ETB receptors in rats.","volume":"199","author":"Fukuroda","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension.","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension.","volume":"353","author":"Galie","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).","volume":"46","author":"Galie","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension.","volume":"61","author":"Gali\u00e9","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1161\/circulationaha.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.","volume":"117","author":"Galie","year":"2008","journal-title":"Circulation"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/491963","article-title":"TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-&#x3b4. Upregulation.","volume":"2014","author":"Gao","year":"2014","journal-title":"PPAR Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10741-017-9612-9","article-title":"Drug-induced pulmonary arterial hypertension: a review.","volume":"22","author":"Garg","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047662","article-title":"Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.","volume":"7","author":"Gatfield","year":"2012","journal-title":"PLoS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/cvr\/24.3.239","article-title":"Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure.","volume":"24","author":"Gennari","year":"1990","journal-title":"Cardiovasc. Res."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1462799","article-title":"Riociguat for the treatment of pulmonary arterial hypertension: a randomised, double-blind, placebo-controlled study (PATENT-1).","volume":"142","author":"Ghofrani","year":"2012","journal-title":"Chest"},{"key":"B80","first-page":"1550","article-title":"Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis.","volume":"341","author":"Giaid","year":"","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/nejm199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.","volume":"328","author":"Giaid","year":"","journal-title":"N. Engl. J. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/ana.22126","article-title":"Capsaicin induces degeneration of cutaneous autonomic nerve fibers.","volume":"68","author":"Gibbons","year":"2010","journal-title":"Ann. Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/01.shk.0000183395.29014.7c","article-title":"Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia.","volume":"24","author":"Gomes","year":"2005","journal-title":"Shock"},{"key":"B84","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/bja\/ael112","article-title":"Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease.","volume":"97","author":"Goyal","year":"2006","journal-title":"Br. J. Anaesth."},{"key":"B85","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1091\/mbc.6.5.509","article-title":"Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor.","volume":"6","author":"Grady","year":"1995","journal-title":"Mol. Biol. Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1476-5381.1987.tb11382.x","article-title":"Calcitonin gene-related peptide (CGRP) is a potent non-endothelium-dependent inhibitor of coronary vasomotor tone.","volume":"92","author":"Greenberg","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00441-002-0616-x","article-title":"Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues.","volume":"310","author":"Hagner","year":"2002","journal-title":"Cell Tissue Res."},{"key":"B88","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.151.3.1491","article-title":"Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling.","volume":"151","author":"Haines","year":"1993","journal-title":"J. Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1476-5381.1994.tb17020.x","article-title":"Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.","volume":"113","author":"Hall","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0008-6363(95)00172-7","article-title":"Nebulized nitric oxide\/nucleophile adduct reduces chronic pulmonary hypertension.","volume":"31","author":"Hampl","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-011-0921-x","article-title":"TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice.","volume":"461","author":"Hao","year":"2011","journal-title":"Pflugers Arch."},{"key":"B92","doi-asserted-by":"publisher","first-page":"C550","DOI":"10.1152\/ajpcell.1985.248.5.C550","article-title":"Characterization of a coronary vasoconstrictor produced by cultured endothelial cells.","author":"Hickey","year":"1985","journal-title":"Am. J. Physiol."},{"key":"B93","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.159.11.5654","article-title":"Human monocytes and macrophages express substance P and neurokinin-1 receptor.","volume":"159","author":"Ho","year":"1997","journal-title":"J. Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/cvr\/cvq077","article-title":"Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells.","volume":"87","author":"Holton","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/0306-4522(88)90064-4","article-title":"Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides.","volume":"24","author":"Holzer","year":"1988","journal-title":"Neuroscience"},{"key":"B96","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(25)06664-5","article-title":"Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons.","volume":"43","author":"Holzer","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.neuroscience.2009.09.001","article-title":"Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia.","volume":"164","author":"Hoover","year":"2009","journal-title":"Neuroscience"},{"key":"B98","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1536\/ihj.46.867","article-title":"Increased circulating calcitonin gene-related peptide in congestive heart failure caused by congenital heart disease.","volume":"46","author":"Hsu","year":"2005","journal-title":"Int. Heart J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1183\/09031936.04.00028404","article-title":"Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.","volume":"24","author":"Humbert","year":"2004","journal-title":"Eur. Respir. J."},{"key":"B100","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacc.2009.04.013","article-title":"The 4th World Symposium on Pulmonary Hypertension. Introduction.","author":"Humbert","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry.","volume":"173","author":"Humbert","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/circulationaha.106.627588","article-title":"Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts.","volume":"114","author":"Ieda","year":"2006","journal-title":"Circulation"},{"key":"B103","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1124\/jpet.108.142976","article-title":"Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist.","volume":"327","author":"Iglarz","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00000441-199207000-00005","article-title":"Cicletanine blunts the pulmonary pressor response to acute hypoxia in rats.","volume":"304","author":"Jin","year":"1992","journal-title":"Am. J. Med. Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1139\/y97-058","article-title":"Afferent C-fibres release substance P and glutamate.","volume":"75","author":"Juranek","year":"1997","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B106","first-page":"171","article-title":"Capsaicin pre- and post-treatment on rat monocrotaline pneumotoxicity.","volume":"43","author":"Katzman","year":"2000","journal-title":"Chin. J. Physiol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/01902149209031681","article-title":"Dynamic aspects of regulatory lung peptides in chronic hypoxic pulmonary hypertension.","volume":"18","author":"Keith","year":"1992","journal-title":"Exp. Lung Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"H1571","DOI":"10.1152\/ajpheart.2000.279.4.H1571","article-title":"Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats.","volume":"279","author":"Keith","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1139\/y10-041","article-title":"Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1.","volume":"88","author":"Kelland","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1152\/jappl.1993.75.4.1615","article-title":"Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.","volume":"75","author":"Klinger","year":"1993","journal-title":"J. Appl. Physiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/01.HYP.29.1.506","article-title":"Role of substance P in blood pressure regulation in salt-dependent experimental hypertension.","author":"Kohlmann","year":"1997","journal-title":"Hypertension"},{"key":"B112","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1111\/1523-1747.ep12462082","article-title":"Structure, functions, and mechanisms of substance P receptor action.","author":"Krause","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-291X(85)90992-1","article-title":"Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells.","volume":"132","author":"Kubota","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B114","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1995.tb02008.x","article-title":"Endothelin-1 and the regulation of vascular tone.","volume":"22","author":"La","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1161\/01.CIR.101.14.1665","article-title":"Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries.","volume":"101","author":"Laine","year":"2000","journal-title":"Circulation"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1172\/JCI14172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.","volume":"111","author":"Landmesser","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B117","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1111\/bph.12987","article-title":"Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function.","volume":"172","author":"Lang","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043433","article-title":"The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.","volume":"7","author":"Lang","year":"2012","journal-title":"PLoS One"},{"key":"B119","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00500282","article-title":"Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation.","volume":"310","author":"Lembeck","year":"1979","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/HJH.0b013e328329bbd7","article-title":"Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension.","volume":"27","author":"Li","year":"2009","journal-title":"J. Hypertens."},{"key":"B121","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.1152\/ajprenal.00434.2012","article-title":"Renal protective effects of alpha-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension.","volume":"304","author":"Li","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1139\/y10-067","article-title":"Reversal of isoprenaline-induced cardiac remodeling by rutaecarpine via stimulation of calcitonin gene-related peptide production.","volume":"88","author":"Li","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/hypertensionaha.114.03105","article-title":"Transient receptor potential vanilloid 1 activation by dietary capsaicin promotes urinary sodium excretion by inhibiting epithelial sodium channel \u03b1 subunit\u2013mediated sodium reabsorption.","volume":"64","author":"Li","year":"2014","journal-title":"Hypertension"},{"key":"B124","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00210-016-1240-8","article-title":"Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats.","volume":"389","author":"Li","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/DDDT.S117277","article-title":"Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.","volume":"11","author":"Lian","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0304-3940(86)90421-0","article-title":"In vivo release of substance P in the nucleus tractus solitarii increases during hypoxia.","volume":"69","author":"Lindefors","year":"1986","journal-title":"Neurosci. Lett."},{"key":"B127","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0304-3959(90)91110-5","article-title":"Capsaicin: actions on nociceptive C-fibres and therapeutic potential.","volume":"41","author":"Lynn","year":"1990","journal-title":"Pain"},{"key":"B128","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neulet.2013.05.028","article-title":"CGRP inhibits norepinephrine induced apoptosis with restoration of Bcl-2\/Bax in cultured cardiomyocytes of rat.","volume":"549","author":"Ma","year":"2013","journal-title":"Neurosci. Lett."},{"key":"B129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00178976","article-title":"Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery.","volume":"342","author":"Maggi","year":"1990","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B130","first-page":"6","article-title":"Neurobiology of substance P and the NK1 receptor.","author":"Mantyh","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2174\/092986706777441968","article-title":"Endothelin-1: the yin and yang on vascular function.","volume":"13","author":"Marasciulo","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-2999(86)90661-8","article-title":"Cardiovascular effects of human and rat CGRP compared in the rat and other species.","volume":"123","author":"Marshall","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00424-012-1136-5","article-title":"Involvement of TRPV1 and TRPV4 channels in migration of rat pulmonary arterial smooth muscle cells.","volume":"464","author":"Martin","year":"2012","journal-title":"Pflugers Arch."},{"key":"B134","doi-asserted-by":"publisher","first-page":"29","DOI":"10.29245\/2572.942X\/2016\/2.1020","article-title":"Substance P and antagonists of the neurokinin-1 receptor in neuroinflammation associated with infectious and neurodegenerative diseases of the central nervous system.","volume":"1","author":"Martinez","year":"2016","journal-title":"J. Neurol. Neuromed."},{"key":"B135","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","article-title":"Neuropeptide Substance P and the Immune Response.","volume":"73","author":"Mashaghi","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/00004872-199210120-00010","article-title":"Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases.","volume":"10","author":"Masuda","year":"1992","journal-title":"J. Hypertens."},{"key":"B137","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0006-291X(89)91684-7","article-title":"Abundance of endothelin-3 in rat intestine, pituitary gland and brain.","volume":"164","author":"Matsumoto","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B138","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1476-5381.1968.tb00452.x","article-title":"Actions of substance P on the general, pulmonary, and coronary haemodynamics and metabolism of intact dogs.","volume":"32","author":"Maxwell","year":"1968","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1152\/jappl.1989.67.3.1265","article-title":"Calcitonin gene-related peptide vasodilation of human pulmonary vessels.","volume":"67","author":"McCormack","year":"","journal-title":"J. Appl. Physiol."},{"key":"B140","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/0024-3205(89)90004-0","article-title":"Effect of sensory neuropeptides on canine bronchial and pulmonary vessels in vitro.","volume":"45","author":"McCormack","year":"","journal-title":"Life Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.CIR.77.5.1072","article-title":"Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.","volume":"77","author":"McEwan","year":"1988","journal-title":"Circulation"},{"key":"B142","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4065\/83.8.923","article-title":"Design of the REVEAL registry for US patients with pulmonary arterial hypertension.","volume":"83","author":"McGoon","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"B143","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1183\/09059180.00008211","article-title":"REVEAL: a contemporary US pulmonary arterial hypertension registry.","volume":"21","author":"McGoon","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.jacc.2015.03.540","article-title":"Management of pulmonary arterial hypertension.","volume":"65","author":"McLaughlin","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1183\/09031936.05.00054804","article-title":"Survival with first-line bosentan in patients with primary pulmonary hypertension.","volume":"25","author":"McLaughlin","year":"2005","journal-title":"Eur. Respir. J."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-Related pulmonary hypertension: analytic review of 131 cases.","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/01.CIR.92.6.1539","article-title":"Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension.","volume":"92","author":"Mehta","year":"1995","journal-title":"Circulation"},{"key":"B148","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/cvr\/cvr244","article-title":"Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.","volume":"92","author":"Melendez","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1022150819223","article-title":"The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension.","volume":"8","author":"Michelakis","year":"2003","journal-title":"Heart Fail. Rev."},{"key":"B150","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/01.CIR.96.2.689","article-title":"Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.","volume":"96","author":"Mitani","year":"1997","journal-title":"Circulation"},{"key":"B151","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5339\/gcsp.2014.53","article-title":"Role of prostacyclin in pulmonary hypertension.","volume":"2014","author":"Mitchell","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"B152","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1113\/expphysiol.2007.038588","article-title":"Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.","volume":"93","author":"Mitchell","year":"2008","journal-title":"Exp. Physiol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.RES.73.5.887","article-title":"Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.","volume":"73","author":"Miyauchi","year":"1993","journal-title":"Circ. Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/263663a0","article-title":"An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.","volume":"263","author":"Moncada","year":"1976","journal-title":"Nature"},{"key":"B155","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1513\/pats.200605-118SF","article-title":"Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?","volume":"3","author":"Morrell","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"B156","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension.","author":"Morrell","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1113\/ep085347","article-title":"Raised arterial blood pressure in neurokinin-1 receptor-deficient mice (NK1R(-\/-) ): evidence for a neural rather than a vascular mechanism.","volume":"101","author":"Moyes","year":"2016","journal-title":"Exp. Physiol."},{"key":"B158","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0306-4522(85)90156-3","article-title":"Calcitonin gene-related peptide in cardiovascular tissues of the rat.","volume":"14","author":"Mulderry","year":"","journal-title":"Neuroscience"},{"key":"B159","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0167-0115(85)90194-6","article-title":"Distribution and chromatographic characterisation of CGRP-like immunoreactivity in the brain and gut of the rat.","volume":"12","author":"Mulderry","year":"","journal-title":"Regul. Pept."},{"key":"B160","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0306-4522(85)90156-3","article-title":"Calcitonin gene-related peptide in cardiovascular tissues of the rat.","volume":"14","author":"Mulderry","year":"","journal-title":"Neuroscience"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/sj.bjp.0704984","article-title":"Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.","volume":"137","author":"Murray","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jacc.2014.05.074","article-title":"Pro-substance p for evaluation of risk in acute myocardial infarction.","volume":"64","author":"Ng","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B163","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-444-63407-8.00020-4","article-title":"\u201cChapter 20 - Antihypertensive Drugs,\u201d in","author":"Odili","year":"2014","journal-title":"Side Effects of Drugs Annual"},{"key":"B164","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0922-4106(92)90109-9","article-title":"The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis.","volume":"225","author":"Ohlstein","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"H880","DOI":"10.1152\/ajpheart.1994.267.3.H880","article-title":"Human basilar and middle cerebral arteries exhibit endothelium-dependent responses to peptides.","volume":"267","author":"Onoue","year":"1994","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from L-arginine.","volume":"333","author":"Palmer","year":"1988","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/jid.2014.423","article-title":"Substance P stimulates endothelin 1 secretion via endothelin-converting enzyme 1 and promotes melanogenesis in human melanocytes.","volume":"135","author":"Park","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00424-015-1704-6","article-title":"Effect of hypoxia on TRPV1 and TRPV4 channels in rat pulmonary arterial smooth muscle cells.","volume":"468","author":"Parpaite","year":"2016","journal-title":"Pflugers Arch."},{"key":"B169","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-291X(85)90388-2","article-title":"Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells.","volume":"130","author":"Payan","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B170","doi-asserted-by":"crossref","first-page":"783s","DOI":"10.4049\/jimmunol.135.2.783","article-title":"Modulation of lymphocyte function by sensory neuropeptides.","author":"Payan","year":"1985","journal-title":"J. Immunol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension.","volume":"30","author":"Peacock","year":"2007","journal-title":"Eur. Respir. J."},{"key":"B172","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3565(24)35294-2","article-title":"Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery.","volume":"292","author":"Pedersen","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B173","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1476-5381.1995.tb15893.x","article-title":"Substance P-induced relaxation and hyperpolarization in human cerebral arteries.","volume":"115","author":"Petersson","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1096\/fasebj.9.12.7672512","article-title":"Endothelin receptors and calcium signaling.","volume":"9","author":"Pollock","year":"1995","journal-title":"FASEB J."},{"key":"B175","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/07420529309073886","article-title":"Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach.","volume":"10","author":"Portaluppi","year":"1993","journal-title":"Chronobiol. Int."},{"key":"B176","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5694\/mja16.00468","article-title":"Update on pharmacotherapy for pulmonary hypertension.","volume":"205","author":"Prior","year":"2016","journal-title":"Med. J. Aust."},{"key":"B177","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/FJC.0b013e3181eb4e75","article-title":"Heme-dependent and independent soluble guanylate cyclase activators and vasodilation.","volume":"56","author":"Priviero","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension.","volume":"369","author":"Pulido","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B179","doi-asserted-by":"publisher","first-page":"L86","DOI":"10.1152\/ajplung.00356.2002","article-title":"Targeted blocking of gene expression for CGRP receptors elevates pulmonary artery pressure in hypoxic rats.","volume":"285","author":"Qing","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijcard.2016.11.205","article-title":"TRPV1 channels in cardiovascular system: a double edged sword?","volume":"228","author":"Randhawa","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-1838(86)90041-X","article-title":"Peptidergic innervation of human atrial myocardium: an electron microscopical and immunocytochemical study.","volume":"17","author":"Rechardt","year":"1986","journal-title":"J. Auton. Nerv. Syst."},{"key":"B182","doi-asserted-by":"publisher","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study.","volume":"107","author":"Rich","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1959270","article-title":"Substance P receptor signaling mediates doxorubicin-induced cardiomyocyte apoptosis and triple-negative breast cancer chemoresistance.","volume":"2016","author":"Robinson","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/645153","article-title":"Substance P receptor antagonism: a potential novel treatment option for viral-myocarditis.","volume":"2015","author":"Robinson","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/01.STR.24.7.1043","article-title":"Endothelium-dependent effects of substance P and calcitonin gene-related peptide on mouse pial arterioles.","volume":"24","author":"Rosenblum","year":"1993","journal-title":"Stroke"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.6089345","article-title":"Alternative RNA processing: determining neuronal phenotype.","volume":"225","author":"Rosenfeld","year":"1984","journal-title":"Science"},{"key":"B187","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/304129a0","article-title":"Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.","volume":"304","author":"Rosenfeld","year":"1983","journal-title":"Nature"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1164\/rccm.2208008","article-title":"Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents.","volume":"166","author":"Rubin","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00005344-199803000-00006","article-title":"Long-term effects of cicletanine on secondary pulmonary hypertension.","volume":"31","author":"Saadjian","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1164\/rccm.200302-282OC","article-title":"Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats.","volume":"169","author":"Schermuly","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B191","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1161\/CIRCULATIONAHA.106.676809","article-title":"Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.","volume":"115","author":"Schermuly","year":"2007","journal-title":"Circulation"},{"key":"B192","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.4049\/jimmunol.158.8.3895","article-title":"Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells.","volume":"158","author":"Schratzberger","year":"1997","journal-title":"J. Immunol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1161\/01.RES.0000148633.93110.24","article-title":"Vanilloid receptor TRPV 1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction.","volume":"95","author":"Scotland","year":"2004","journal-title":"Circ. Res."},{"key":"B194","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1161\/01.CIR.0000074226.20466.B1","article-title":"Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.","volume":"107","author":"Sebkhi","year":"2003","journal-title":"Circulation"},{"key":"B195","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.RES.62.2.196","article-title":"Substance P-induced pulmonary vasoreactivity in isolated perfused guinea pig lung.","volume":"62","author":"Selig","year":"1988","journal-title":"Circ. Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.CIR.89.3.1203","article-title":"Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.","volume":"89","author":"Seo","year":"1994","journal-title":"Circulation"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/j.1476-5381.1995.tb15028.x","article-title":"Endothelium-dependent contraction in intrapulmonary arteries: mediation by endothelial NK1 receptors and TXA2.","volume":"115","author":"Shirahase","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension.","volume":"373","author":"Sitbon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/thx.2005.040618","article-title":"Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.","volume":"60","author":"Sitbon","year":"2005","journal-title":"Thorax"},{"key":"B200","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0196-9781(84)90020-2","article-title":"Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase.","volume":"5","author":"Skidgel","year":"1984","journal-title":"Peptides"},{"key":"B201","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.npep.2010.12.002","article-title":"Calcitonin gene-related peptide (CGRP) and its role in hypertension.","volume":"45","author":"Smillie","year":"2011","journal-title":"Neuropeptides"},{"key":"B202","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1183\/09031936.03.00027903","article-title":"Substance P-induced pulmonary vascular remodelling in precision cut lung slices.","volume":"22","author":"Springer","year":"2003","journal-title":"Eur. Respir. J."},{"key":"B203","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"B204","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0016-5085(89)90627-6","article-title":"Mast cells are closely apposed to nerves in the human gastrointestinal mucosa.","volume":"97","author":"Stead","year":"1989","journal-title":"Gastroenterology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1073\/pnas.84.9.2975","article-title":"Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves.","volume":"84","author":"Stead","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B206","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.coph.2004.12.008","article-title":"Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.","volume":"5","author":"Steiner","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0167-5273(92)90274-7","article-title":"Calcitonin gene-related peptide: a haemodynamic study of a novel vasodilator in patients with severe chronic heart failure.","volume":"37","author":"Stevenson","year":"1992","journal-title":"Int. J. Cardiol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"B209","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/s0009-9236(96)90200-3","article-title":"Substance P in human hand veins in vivo: tolerance, efficacy, potency, and mechanism of venodilator action.","volume":"60","author":"Strobel","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/0006-291X(91)91704-G","article-title":"Molecular cloning, structural characterization and functional expression of the human substance P receptor.","volume":"179","author":"Takeda","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1476-5381.1994.tb17112.x","article-title":"Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.","volume":"113","author":"Thompson","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"H681","DOI":"10.1152\/ajpheart.1992.263.3.H681","article-title":"CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension.","author":"Tjen","year":"1992","journal-title":"Am. J. Physiol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-0115(98)00007-X","article-title":"Sensory CGRP depletion by capsaicin exacerbates hypoxia-induced pulmonary hypertension in rats.","volume":"74","author":"Tjen","year":"1998","journal-title":"Regul. Pept."},{"key":"B214","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1476-5381.1991.tb12256.x","article-title":"Comparison of endothelium-dependent responses of monkey cerebral and temporal arteries.","volume":"102","author":"Toda","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1254\/jjp.83.20","article-title":"Capsaicin receptor in the pain pathway.","volume":"83","author":"Tominaga","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1002\/phar.2078","article-title":"Serious liver injury associated with macitentan: a case report.","volume":"38","author":"Tran Thao","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B217","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0735-1097(92)90528-U","article-title":"Response of the pulmonary circulation to acetylcholine, calcitonin gene-related peptide, substance P and oral nicardipine in patients with primary pulmonary hypertension.","volume":"19","author":"Uren","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","article-title":"An unidentified depressor substance in certain tissue extracts.","volume":"72","author":"V Euler","year":"1931","journal-title":"J. Physiol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2796.1991.tb00452.x","article-title":"Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.","volume":"230","author":"Valdemarsson","year":"1991","journal-title":"J. Intern. Med."},{"key":"B220","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0149-7634(96)00023-1","article-title":"Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors.","volume":"21","author":"van Rossum","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B221","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00005344-199401000-00016","article-title":"Diethylamine\/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs.","volume":"23","author":"Vanderford","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/hrt.2003.029405","article-title":"Free radical production by dysfunctional eNOS.","volume":"90","author":"Verhaar","year":"2004","journal-title":"Heart"},{"key":"B223","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.106.677245","article-title":"Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.","volume":"116","author":"Vermeersch","year":"2007","journal-title":"Circulation"},{"key":"B224","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/sj.bjp.0700879","article-title":"Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization.","volume":"120","author":"Wallerstedt","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00232-008-9121-9","article-title":"Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells.","volume":"223","author":"Wang","year":"2008","journal-title":"J. Membr. Biol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0022-2828(81)90321-7","article-title":"Peptidergic innervation (substance P) in the human heart.","volume":"13","author":"Weihe","year":"1981","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"13868","DOI":"10.1074\/jbc.M111.334896","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel.","volume":"287","author":"Wen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/cvr\/cvx148","article-title":"Treatment strategies for the right heart in pulmonary hypertension.","volume":"113","author":"Westerhof","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"B229","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/01.RES.66.4.900","article-title":"Immunohistochemical demonstration of human cardiac innervation before and after transplantation.","volume":"66","author":"Wharton","year":"1990","journal-title":"Circ. Res."},{"key":"B230","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1164\/rccm.200411-1587OC","article-title":"Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.","volume":"172","author":"Wharton","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B231","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1210\/edrv-17-5-533","article-title":"Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials.","volume":"17","author":"Wimalawansa","year":"1996","journal-title":"Endocr. Rev."},{"key":"B232","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1152\/jappl.1985.59.4.1098","article-title":"Opposing hemodynamic effects of substance P on pulmonary vasculature in rabbits.","volume":"59","author":"Worthen","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/hypertensionaha.115.06223","article-title":"Ameliorating endothelial mitochondrial dysfunction restores coronary function via transient receptor potential vanilloid 1-mediated protein kinase A\/uncoupling protein 2 pathway.","volume":"67","author":"Xiong","year":"2016","journal-title":"Hypertension"},{"key":"B234","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/01902148.2016.1271481","article-title":"Capsaicin pretreatment reversed pulmonary arterial hypertension by alleviating inflammation via p38MAPK pathway.","volume":"43","author":"Xu","year":"2017","journal-title":"Exp. Lung Res."},{"key":"B235","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells.","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"B236","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s13238-016-0353-7","article-title":"Understand spiciness: mechanism of TRPV1 channel activation by capsaicin.","volume":"8","author":"Yang","year":"2017","journal-title":"Protein Cell"},{"key":"B237","first-page":"139","article-title":"Levels of plasma endothelin and calcitonin gene-related peptide in children with congenital heart disease and pulmonary hypertension.","volume":"2","author":"Zhang","year":"2006","journal-title":"World J. Pediatr."},{"key":"B238","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/hc2901.093117","article-title":"Sildenafil inhibits hypoxia-induced pulmonary hypertension.","volume":"104","author":"Zhao","year":"2001","journal-title":"Circulation"},{"key":"B239","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.athoracsur.2007.03.067","article-title":"Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension.","volume":"84","author":"Zhao","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"B240","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/1570159X13666150331223118","article-title":"TRP channels in respiratory pathophysiology: the role of oxidative, chemical irritant and temperature stimuli.","volume":"13","author":"Zholos","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1152\/jappl.1993.75.6.2781","article-title":"Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension.","volume":"75","author":"Zhou","year":"1993","journal-title":"J. Appl. Physiol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T14:02:24Z","timestamp":1751810544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":241,"alternative-id":["10.3389\/fphys.2018.01167"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2018.01167","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"article-number":"1167"}}